Digital Look

Welcome to Digital Look++,
you are not logged in

International Biotech Trust (IBT)

Investment Firms

568.00p

Trade now with Barclays Stockbrokers

Select chart: EPS | Dividend | Revenue

Period Ending	Period	Revenue (£m)	Pre-tax (£m)	EPS	Dividend
28-Feb-25	Interim	0.29	(2.01)	(5.60)p	15.56p

Year Ending	Revenue (£m)	Pre-tax (£m)	EPS	P/E	PEG	EPS Grth.	Div	Yield
31-Aug-20	1.13	(2.06)	(5.79)p	n/a	n/a	n/a	24.80p	3.4%
31-Aug-21	1.11	(2.59)	(6.80)p	n/a	n/a	n/a	28.40p	3.9%
31-Aug-22	1.11	(2.78)	(7.13)p	n/a	n/a	n/a	31.40p	4.8%
31-Aug-23	0.86	(3.75)	(9.53)p	n/a	n/a	n/a	28.20p	4.4%
31-Aug-24	1.26	(3.36)	(9.16)p	n/a	n/a	n/a	28.40p	4.2%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Forecasts data is not available for this company.

	5 Yr High	5 Yr Low	5 Yr Avg	Curr / Avg
Latest	n/a	n/a	n/a	0

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

Find out about IFRS and how this affects the financial infomation for all UK companies.